Fingerprint
Dive into the research topics of 'Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer
Sara M. Tolaney, William T. Barry, Chau T. Dang, Denise A. Yardley, Beverly Moy, P. Kelly Marcom, Kathy S. Albain, Hope S. Rugo, Matthew Ellis, Iuliana Shapira, Antonio C. Wolff, Lisa A. Carey, Beth A. Overmoyer, Ann H. Partridge, Hao Guo, Clifford A. Hudis, Ian E. Krop, Harold J. Burstein, Eric P. Winer
Research output: Contribution to journal › Article › peer-review
383
Scopus
citations